Avidity Partners Management’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $42.1M | Sell |
|
|||||
|
2023
Q2 | $65.8M | Sell |
|
|||||
|
2023
Q1 | $50.4M | Sell |
|
|||||
|
2022
Q4 | $104M | Buy |
|
|||||
|
2022
Q3 | $91.5M | Buy |
|
|||||
|
2022
Q2 | $101M | Buy |
|
|||||
|
2022
Q1 | $147M | Buy |
|
|||||
|
2021
Q4 | $228M | Buy |
|
|||||
|
2021
Q3 | $166M | Buy |
|
|||||
|
2021
Q2 | $115M | Buy |
|
|||||
|
2021
Q1 | $54.8M | Buy |
|
|||||
|
2020
Q4 | $59M | Buy |
|
|||||
|
2020
Q3 | $29.6M | Buy |
|
|||||
|
2020
Q2 | $32.4M | Buy |
|